{
    "2019-07-12": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Drug Pricing Woes Linger on Repealing Drug Rebate Proposal",
                "features": {
                    "keywords": [
                        "Drug",
                        "Pricing",
                        "Repealing",
                        "Rebate",
                        "Proposal"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "S&P 500 Movers: ILMN, JBHT",
                "features": {
                    "keywords": [
                        "S&P 500",
                        "Movers",
                        "ILMN",
                        "JBHT"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "transportation"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-22",
                "original_text": "Health Care stocks help lead Wall Street rally",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "stocks",
                        "Wall",
                        "Street",
                        "rally"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Amgen",
                        "Scrap",
                        "Pivotal",
                        "Study",
                        "Alzheimer's",
                        "Prevention",
                        "Drug"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine",
                "features": {
                    "keywords": [
                        "Lilly",
                        "OVERCOME",
                        "Observational",
                        "Study",
                        "Inconsistent",
                        "Sub-Optimal",
                        "Treatment",
                        "Migraine"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-11-08",
                "original_text": "AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of EmgalityÂ® (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine",
                "features": {
                    "keywords": [
                        "AHS",
                        "Post-Hoc",
                        "Analyses",
                        "Phase",
                        "3",
                        "Pivotal",
                        "Studies",
                        "Emgality",
                        "Improvements",
                        "Daily",
                        "Functioning",
                        "Reductions",
                        "Disability",
                        "Chronic",
                        "Episodic",
                        "Migraine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}